Risk in Stopping Rivaroxaban and Warfarin Temporarily in AFRisk in Stopping Rivaroxaban and Warfarin Temporarily in AF

The temporary interruption resulted in very few strokes or thrombotic events and a low rate of bleeding in both rivaroxaban- and warfarin-treated patients. Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news